Casa Physicians Alliance News

RotaTeq® (Rotavirus Vaccine, Live, Oral, Pentavalent): Celebrating 10 Years of FDA Approval 2006-2016

We are excited to announce that RotaTeq is celebrating 10 years of FDA approval.

Thank you for your efforts in vaccinating appropriate patients against rotavirus gastroenteritis over these past 10 years. We look forward to celebrating more milestones with you in the future.

RotaTeq is the only rotavirus vaccine with an indication that includes the G2 serotype. G2 has been shown to be the second most common cause of RGE in the United States overall after G1, although rotavirus serotype distribution varied by region and year. 1,a

aAccording to the most recently published data.

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes G1, G2, G3, and G4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks.

The vaccination series consists of 3 ready-to-use liquid doses of RotaTeq administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4- to 10-week intervals. The third dose should not be given after 32 weeks of age.

Selected Safety Information

RotaTeq should not be administered to infants with a demonstrated history of hypersensitivity to the vaccine or any component of the vaccine.

Infants with Severe Combined Immunodeficiency Disease (SCID) should not receive RotaTeq. Post-marketing reports of gastroenteritis, including severe diarrhea and prolonged shedding of vaccine virus, have been reported in infants who were administered RotaTeq and later identified as having SCID.

Infants with a history of intussusception should not receive RotaTeq.

No safety or efficacy data are available from clinical trials regarding the administration of RotaTeq to infants who are potentially immunocompromised.

In a post-marketing observational study in the US, cases of intussusception were observed in temporal association within 21 days following the first dose of RotaTeq, with a clustering of cases in the first 7 days.

No safety or efficacy data are available for administration of RotaTeq ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to infants with a history of gastrointestinal disorders.

Vaccine virus transmission from vaccine recipient to nonvaccinated contacts has been reported. Caution is advised when considering whether to administer RotaTeq to individuals with immunodeficient contacts.

In clinical trials, the most common adverse events included diarrhea, vomiting, irritability, otitis media, nasopharyngitis, and bronchospasm.

In post-marketing experience, intussusception (including death) and Kawasaki disease have been reported in infants who have received RotaTeq.

RotaTeq may not protect all vaccine recipients against rotavirus.

Before administering RotaTeq, please read the accompanying Prescribing Information. The Patient Product Information also is available. For additional copies of the Prescribing Information, please call 800-672-6372, visit, or contact your Merck representative.


Sherif Salib Associate Director, Global Marketing US Pediatric Franchise

Reference: 1. Hull JJ, Teel EN, Kerin TK, et al; for National Rotavirus Strain Surveillance System. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 2011;30 (suppl 1):S42–S47.

Posted by Chris Dixon on 26th February, 2016 | Comments | Trackbacks
Tags: Medical Buying Group, Healthcare Professional, Merck, Group Purchasing Organization, CASA Physicians Alliance, Discount Vaccine Buying Program, Discount Vaccine Program, Discount Vaccines, One Stop Shop, Vaccine Discounts and Rebates, Vaccinate Early, Vaccine Group Purchasing Program, vaccine, Vaccine Savings, Pediatric Vaccine, Physicians Buying Group, Savings on Pediatric Vaccines, Savings on Adolescent Vaccines, Discounts on RotaTeq Vaccine, Rotavirus Vaccine, RotaTeq

Bookmark and Share

The trackback URL for this page is


There are no trackbacks for this post


There are no comments for this post

Post a Comment

HTML is not allowed in comments, http://... will be automatically linked.

Name (required):

Email Address (not displayed):

Comment (required):

To help prevent spam, please enter the word clay here:

CASA Physicians Alliance - A Group Purchasing Organization for Physicians, was started 16 years ago for the sole purpose of joining physicians into a large buying group to obtain the best possible discounts on pediatric, adolescent and adult vaccines. Since then, CASA has forged very successful partnerships on behalf of our members.


May 2018
April 2018
February 2018
August 2017
January 2017
November 2016
October 2016
August 2016
July 2016
June 2016
April 2016
February 2016
January 2016
October 2015
September 2015
August 2015
July 2015
May 2015


ACIP MenB Recommendations (4)
Adacel (3)
Adult Vaccine (7)
Age 16-23 years vaccinations (2)
CASA Discount on Trumenba (2)
CASA Physicians Alliance (21)
CASA Physicians Alliance - Trumenba Discount (4)
CASA offers Discounts on Trumenba (2)
CDC (1)
CDC Recommendation for Trumenba at Rutgers (1)
Cleanovative Solutions (1)
Daptacel (3)
Discount Buying Opportunity (7)
Discount Sanofi Vaccines (10)
Discount Vaccine Buying Program (8)
Discount Vaccine Program (11)
Discount Vaccines (12)
Discounts on RotaTeq Vaccine (1)
Discounts on Trumenba vaccine (2)
EVI (1)
Flu Vaccine (5)
FluMist (2)
Gardasil 9 (2)
Group Purchasing Organization (10)
Hand Sanitizer (1)
Healthcare Professional (14)
IPOL (2)
Influenza (9)
Influenza Vaccine (11)
Medical Buying Group (11)
Medical and Surgical Supplies (2)
Medimmune (2)
Menactra (3)
Meningococcal B Rutgers Outbreak (1)
Meningococcal B Vaccine (8)
Merck (2)
Merck - GARDASIL®9 (1)
Merck - GARDASIL®9 (2)
Merck - GARDASIL®9 (1)
National Council for Aging Care (1)
Office Depot (1)
Office Supplies (1)
One Stop Shop (6)
Patient Notifications (4)
Pediatric Vaccine (7)
Pentacel (1)
Pfizer (7)
Pfizer Trumenba Recommended for Rutgers (1)
Physicians Buying Group (20)
Physicians Buying Group offering Discount on Trumenba Vaccine (4)
Purchasing Program (5)
Quadrivalent Flu Vaccine (10)
Quadrivalent Influenza Vaccine (9)
RotaTeq (1)
Rotavirus Vaccine (1)
Rutgers University Trumenba Recommendation (1)
Sanofi (6)
Sanofi Flu Partners Program (10)
Sanofi Fluzone (11)
Sanofi Pasteur (12)
Sanofi Pasteur Flu Vaccine (10)
Savings on Adolescent Vaccines (8)
Savings on Adult Vaccines (10)
Savings on Pediatric Vaccines (9)
Savings on Trumenba (4)
Schedule your Flu Shot (10)
Seasonal Flu (11)
Seasonal Flu for Seniors (1)
Serogroup B Meningococcal MenB vaccine Trumenba (2)
State of New Jersey Dept of Health Trumenba Recommendation for Rutgers Students (1)
TVFC (3)
Tentanus and Diphtheria Toxoids Adsorbed (1)
Texas Vaccines for Children (3)
Trumenba Discounts (7)
Trumenba Info (3)
Trumenba MenB Vaccine (4)
Trumenba Promotion (8)
Trumenba Recommendation (2)
Trumenba Serogroup B vaccine (2)
Trumenba Two Dose Prescribing Information (3)
Vaccinate Early (7)
Vaccination Recommendation Trumenba (2)
Vaccine Coding (5)
Vaccine Discounts and Rebates (13)
Vaccine Group (6)
Vaccine Group Purchasing Program (13)
Vaccine Inventory System (1)
Vaccine Reimbursement (6)
Vaccine Savings (13)
VaxServe (2)
Vendor Promotion (2)
Vital Oxide (1)
Zylast (1)
vaccine (14)